About the Authors

Tatjana Braun

Roles Writing – original draft

‡ These authors shared first author on this work.

Affiliation Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany

Sophia Huesmann

Roles Writing – original draft

‡ These authors shared first author on this work.

Affiliation Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany

Kerstin Pfister

Roles Conceptualization, Writing – review & editing

Affiliation Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany

Thomas W. P. Friedl

Roles Conceptualization, Methodology, Writing – review & editing

Affiliation Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany

Andreas Hartkopf

Roles Writing – review & editing

Affiliation Institute of Women’s Health, University Hospital Tübingen, Tübingen, Germany

Klaus Pantel

Roles Methodology

Affiliation Center for Experimental Medicine, Institute of Tumor Biology, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Forca Mehmeti

Roles Conceptualization, Project administration

Affiliation Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany

Franziska Mergel

Roles Conceptualization

Affiliation Department of Gynecology and Obstetrics, SLK-Kliniken Heilbronn, Heilbronn, Germany

Henning Schäffler

Roles Conceptualization

Affiliation Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany

Sabine Heublein

Roles Conceptualization

Affiliation Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany

Lisa Wiesmüller

Roles Conceptualization, Methodology, Validation

Affiliation Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany

Brigitte Rack

Roles Conceptualization, Funding acquisition

Affiliation Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany

Peter A. Fasching

Roles Conceptualization, Data curation

Affiliation Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany

Wolfgang Janni

Roles Conceptualization, Resources, Writing – review & editing

Affiliation Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany

Angelina Fink

Roles Visualization, Writing – original draft

* angelina.fink@uniklinik-ulm.de

Affiliation Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: Tatjana Braun: none Sophia Huesmann: none Kerstin Pfister: Honoraria from Gilead Sciences, Novartis and Pfizer. Thomas W. P. Friedl: Honoraria from Lilly and Novartis, unrelated to this work. Andreas Hartkopf received honoraria and travel support from: Roche, Novartis, Lilly, MSD, AstraZeneca, Agendia, Seagen, GSK, ExactScience, Riemser, Teva, Onkowissen, Gilead, Menarini Stemline, Seagen, Pfizer, Amgen, Pierre Fabre, Eisai, DaichiiSankyo, Thieme, Veracyte, Springer Klaus Pantel: (last 3 years): Grant/Research support from: EU/IMI GUIDE.MRD EFPIA, EU PANCAID, ERC; Honoraria from: NRICH, BMS, Menarini, Novartis, Roche, MSD, Guardant Health Forca Mehmeti: none Franziska Mergel received honoraria from Novartis and travel support from Lilly. Henning Schäffler received honoraria for lectures and participation in advisory boards: Gilead, Novartis. Travel expenses: Novartis, Gilead and Daichi Sankyo. Sabine Heublein: Advisory activity: MSD, Novartis, Eisai; Travel grants: Astra Zeneca, Novartis, GSK; Industry research funding: Novartis, SAGA; Honoraria: Roche, Pfizer, Astra Zeneca, GSK, Novartis, MSD, Clovis, Immunogen, Abbvie. Lisa Wiesmüller: none Brigitte Rack: Honoraria and research funding by AstraZeneca and Novartis. Peter A. Fasching: Personal fees from Novartis, grants from Biontech, grants and personal fees from Pfizer, personal fees from Daiichi-Sankyo, personal fees from Astra Zeneca, personal fees from Eisai, personal fees from Merck Sharp & Dohme, grants from Cepheid, personal fees from Lilly, personal fees from SeaGen, personal fees from Roche, personal fees from Agendia, personal fees from Gilead, personal fees from Mylan, personal fees from Menarini, personal fees from Veracyte, personal fees from GuardantHealth, during the conduct of the study; and Translational Research in Oncology (TRIO). Wolfgang Janni: Unrestricted research grants by Menarini BioSystems and Neogenomics. Angelina Fink: Honoraria and travel support from Clovis Oncology, Novartis, Pfizer, GSK, Roche.